Get alerts of updates about «SeroSelectTB»
You have subscribed to alerts about:
- SeroSelectTB
Project
SeroSelectTB - project description
Published Updated
SeroSelectTB is a multinational project coordinated by the Norwegian Institute of Public Health.
Summary
The performance of a new triage test for active tuberculosis, SeroSelectTB, will be qualified in multi-centre randomised controlled trials at health-posts in South Africa, Tanzania and Ethiopia. Cost effectiveness evaluations will be conducted to support a value proposition to stakeholders and regulatory authorities, and to support commercialization requirements. Consenting adults will provide blood and saliva samples for screening by SeroSelectTB, and sputum collected for routine TB diagnosis by the health services. Clinical and sociodemographic information will be collected. A reliable rapid test will make it possible to identify and selectively treat those with active TB at the local healthcare level. The expected impact includes accurate same-day diagnosis of patients with active TB, reduction of diagnostic delay and TB transmission, and diagnostic cost-savings for patients and healthcare systems in high burden countries.
SeroSelectTB is a multinational project coordinated by the Norwegian Institute of Public Health (Oslo, Norway). Partners include Stellenbosch University and Lateral Flow Laboratories (South Africa), Kilimanjaro Christian Medical University College (Tanzania), Armauer Hansen Research Institute (Ethiopia), National Institute for Public Health and the Environment (Netherlands), InVivo Biotech Services GmbH (Germany), Aether Dynamics Consulting & Trading GmbH (Austria), and E-MEDDIA (France).
See the full project description at Cristin for more information about results, researchers, contact information etc.
Project participants
Project leader
Carol J C Holm-Hansen, Smittevern, miljø og helse, Norwegian Institute of Public Health
Project participants
Tara Kelly Dolgner, Avdeling for forskningsadministrativ støtte, Norwegian Institute of Public Health
Ida Laake, Smittevern, miljø og helse, Norwegian Institute of Public Health
Grant Theron, University of Stellenbosch
Anna Ojo, University of Stellenbosch
Balthazar Nyombi, Kilimanjaro Christian Medical University College
Kidist Bobosha, AHRI Armauer Hansen Research Institute
Kristin Kremer, National Institute for Public Health and the Environment
Nick Borain, Lateral Flow Laboratories (Pty) Ltd
Tim Welsink, InVivo Biotech Services GmbH
Aleksandar Josifoski, Aether Dynamics Consulting and Trading GmbH
Fatima Gruszka, E-MEDDIA
Miloje Savic, E-MEDDIA